VSEE Health, Inc. received Nasdaq approval on November 28, 2025, to continue its listing after demonstrating compliance with the equity requirement by showing pro forma stockholders' equity of $13.2 million. The compliance plan included transactions like the exercise of warrants and conversion of notes into common stock, which were completed before December 1, 2025.